RecruitingUK-VCSR-2026-00005
Feline hypertrophic cardiomyopathy biomarker screening
Observational · Cardiology · Investigator: Dr Fiona Reid
Feline
Study overview
This observational cohort study evaluates novel circulating biomarkers for early detection and progression of hypertrophic cardiomyopathy in cats. Eligible cats undergo standard echocardiography and a single blood sample. Results may improve screening in predisposed breeds and support earlier clinical intervention.
Condition
Hypertrophic cardiomyopathy
Eligibility criteria
Inclusion
Cats over 1 year with echocardiographic evidence of HCM.
Locations
England, Northern Ireland
Sponsor / institution
Queen's University Belfast
Ethical and regulatory approvals
AWERB approval REF-2026-038
Statement of ethical considerations
Blood sampling during routine cardiology visits only.
Last updated 14 June 2026 · Published 22 March 2026